@hymi

Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008

, , and . Scandinavian Journal of Infectious Diseases 42 (1): 57--60 (2010)PMID: 20055727.

Abstract

A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2\% were resistant to ciprofloxacin and 38.0\% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3\% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.

Links and resources

DOI:
10.3109/00365540903283723
URL:
BibTeX key:
valenza_antimicrobial_2010
search on:

Comments and Reviews  
(0)

There is no review or comment yet. You can write one!

Tags


Cite this publication